The organizations plan to support clients through expanded partnership and offer broader access to Medidata’s AI-powered technologies to accelerate clinical trial development
, /PRNewswire/ — Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata’s life sciences clients and expand the strategic alliance partnership. Over the years, the companies have partnered to deliver a comprehensive framework supporting life sciences clients, emphasizing customer success, patient service desk, implementation, engineering, integrations, and user acceptance testing services using Medidata’s clinical platform and solutions. The renewed relationship aims to enhance responsiveness and improve user satisfaction for life sciences organizations that rely on Medidata’s technology services for clinical trial development.
As part of the multi-year renewal agreement, Cognizant is providing a dedicated team of Medidata Platformspecialists to support their clients in pharmaceutical, biotech, medical device, contract research organizations, and patients using Medidata services. The goal …